2026-08-252026-08-25https://scholars.csmu.edu.tw/handle/123456789/17022Where the available evidence comes from different sources methods are required that can synthesis all of the evidence. To further improve on outcome for patients with endometrial cancer, physician...(詳)臨床醫療決策有賴於多元實際證據的輔助分析。有鑑於過去的研究發展,文獻中臨床隨機試驗與非臨床隨機試驗設計所獲得預後指標的結論莫衷一是,對於子宮內膜癌的預後指標仍然無法獲得一致性的結論。因此,本研...(詳)統合分析復發子宮內膜癌預後因子指標模式Meta AnalysisRecurrent Endometrial CancerPrognosis Factors index Model子宮內膜癌症之創新臨床預後指標模式與醫療科技評估research project